ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott Buys AP214 Hormone From Action Pharma For $110 Million

DOW JONES NEWSWIRES Abbott Laboratories (ABT) took another step to enhance its renal-care pipeline by agreeing to acquire AP214, a hormone analogue that may prevent acute kidney injury during cardiac surgery, from Action Pharma A/S for $110 million in cash. The health-care company has been on a buying spree in recent years in order to reduce its dependence on the anti-inflammatory Humira as the drug's U.S. patent expires in late 2016. Abbott also is in the midst of separating into two publicly traded companies: a medical-products business and a pharmaceutical company to be named AbbVie. Abbott will acquire all global rights to develop and market AP214, and will be responsible for funding all future development and commercialization activities. No later milestone payments or royalties will be paid to the Danish biotech company Action Pharma. Abbott currently has two investigational treatments in development for chronic kidney disease: Bardoxolone, which is in Phase 3 development with Reata Pharmaceuticals, and Atrasentan, a compound discovered by Abbott being evaluated in a Phase 2b study. -By Melodie Warner, Dow Jones Newswires; 212-416-2283;

Stock News for Abbott Labs (ABT)
11/05/201514:41:24Quarterly Report (10-q)
11/03/201508:30:00Zoetis Lifts Outlook as Results Top Views
11/01/201511:23:035 Healthcare Trends to Invest in for the Next 20 Years
10/30/201512:31:00Health is a Marathon, not a Sprint
10/29/201515:52:00'Science' Says Abbott Is a Top Employer
10/28/201519:52:56Your One-Stop Dividend Aristocrat Resource
10/23/201502:04:49The Conservative Total Return Portfolio: 3 Hits And A Miss
10/22/201508:01:00Abbott fait équipe avec Cristiano Ronaldo, star du football...
10/22/201508:01:00Abbott Teams Up with Soccer Star Cristiano Ronaldo to Inspire...
10/22/201508:01:00Abbott Teams Up with Soccer Star Cristiano Ronaldo to Inspire...
10/21/201519:49:00Abbott Teams Up with Football Star Cristiano Ronaldo to Inspire...
10/21/201511:10:00Abbott Labs Profit Rises
10/21/201510:50:00Abbott Labs Profit Rises, Helped by Emerging Markets
10/21/201507:45:00Abbott Reports Third-Quarter 2015 Results
10/20/201517:30:59Notable earnings before Wednesday’s open
10/16/201501:40:00Valeant Probe Reprises Federal Focus on Drug Pricing
10/15/201510:00:00New York Road Runners and Abbott Partner for 2015 TCS New York...
10/12/201516:00:00Abbott Laboratories Dissolving Stent Shows Mixed Results
10/12/201515:57:00Abbott Laboratories Dissolving Stent Shows Mixed Results in Study
10/12/201514:25:00Abbott Announces Positive Clinical Results of Absorb™, the N...

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations